Russell L Delude

Title: Russell L. Delude: Innovator in Inflammatory Condition Treatments

Introduction

Russell L. Delude is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of medical treatments, particularly focusing on inflammatory conditions. With a total of 2 patents, his work has the potential to impact many patients suffering from various inflammatory diseases.

Latest Patents

Delude's latest patents include a method for the prophylaxis or treatment of inflammatory conditions. This method addresses intestinal epithelial inflammation due to conditions such as Crohn's disease or ulcerative colitis. The invention involves administering a therapeutically effective amount of a composition that includes an NAD-related compound, which is delivered in a pharmaceutically acceptable carrier vehicle. Additionally, he has developed a method using pyruvate and its derivatives for treating cytokine-mediated inflammatory conditions. This therapeutic composition targets various inflammatory diseases, including rheumatoid arthritis and asthma.

Career Highlights

Throughout his career, Russell L. Delude has worked with esteemed institutions such as the University of Pittsburgh and North Shore Long Island Jewish Research Institute. His research has focused on innovative methods to treat complex inflammatory conditions, showcasing his dedication to advancing medical science.

Collaborations

Delude has collaborated with notable professionals in his field, including Mitchell P. Fink and Luis Ulloa. These partnerships have contributed to the development of his groundbreaking patents and research.

Conclusion

Russell L. Delude's contributions to the treatment of inflammatory conditions through his innovative patents highlight his role as a significant inventor in the medical field. His work continues to pave the way for new therapeutic approaches that can improve patient outcomes.